热门资讯> 正文
自行车治疗学确保长期核和工业合作伙伴关系，以支持212铅放射性药物开发和商业供应
2025-12-16 14:09
- Execution of a 15-year contract including an option to renew with UK Nuclear Decommissioning Authority for access to up to 400 tonnes of reprocessed uranium (RepU), with the potential to deliver tens of thousands of doses of 212Pb every year
- Partnership with the United Kingdom National Nuclear Laboratory (UKNNL) to scale up the extraction of 228Th from RepU for onward processing into a 212Pb generator
- Agreement with SpectronRx to develop a bespoke wholly owned 212Pb generator, with initial quantities of 212Pb successfully produced
- Bicycle Therapeutics plc (NASDAQ:BCYC), a pharmaceutical compan
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
